levomepromazine orion 25 mg
orion corporation - espoo - levomepromazinmaleat - tablett - 25 mg
lioresal 10 mg
novartis norge (2) - baklofen - tablett - 10 mg
lioresal 25 mg
novartis norge (2) - baklofen - tablett - 25 mg
metalyse 10000 e
orifarm as - tenekteplase - pulver og væske til injeksjonsvæske, oppløsning - 10000 e
otrivin 0.5 mg/ ml
haleon denmark aps - xylometazolinhydroklorid - nesespray, oppløsning - 0.5 mg/ ml
otrivin 1 mg/ ml
haleon denmark aps - xylometazolinhydroklorid - nesespray, oppløsning - 1 mg/ ml
otrivin comp 0.5 mg/ ml / 0.6 mg/ ml
haleon denmark aps - xylometazolinhydroklorid / ipratropiumbromid - nesespray, oppløsning - 0.5 mg/ ml / 0.6 mg/ ml
paramove 49.5 % w/w
solvay chemicals international sa - hydrogenperoksid - konsentrat til behandlingsoppløsning til fisk - 49.5 % w/w
scopoderm 1 mg/72 timer
baxter medical ab - skopolamin - depotplaster - 1 mg/72 timer
alunbrig
takeda pharma a/s - brigatinib - karsinom, ikke-småcellet lunge - antineoplastiske midler - alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase alkpositive advanced nsclc previously treated with crizotinib.